Zujew Laurie, Raibaut Laurent, Chambron Jean-Claude
Institut de Chimie de Strasbourg, UMR 7177 CNRS and University of Strasbourg, 4, rue Blaise Pascal, Strasbourg, F-67081, France.
Chemistry. 2025 Jun 17;31(34):e202501114. doi: 10.1002/chem.202501114. Epub 2025 May 15.
Promising results in preclinical diagnosis based on Zr-immunoPET have fostered the development of efficient chelators for this tetravalent metal. Leads in this area are octadentate ligands obtained by extension of the desferrioxamine B trihydroxamic acid DFO with a fourth bidentate ligand. In the approach reported here, the latter is a natural 6-membered cyclic hydroxamic acid deriving from (L)-ornithine. Its coupling to DFO via an (L)-lysine spacer required that the genuine amine function of the DFO terminus be changed to a carboxylic acid. Such a requirement prompted us to explore short sequences of chemical transformations that would challenge total syntheses leading to the same products. As a matter of fact, the target C-terminal DFO analogue was obtained in benzyl-protected form in three steps from commercially available DFO in 16% overall yield. Our short-step approach allowed us to implement other functionalities without DFO extension: -OH, -OTs, -CHO, -C(O)CH, and -CH═CH.
基于锆免疫正电子发射断层扫描(Zr-immunoPET)的临床前诊断取得的有前景的结果推动了针对这种四价金属的高效螯合剂的开发。该领域的领先者是八齿配体,它是通过用第四个双齿配体扩展去铁胺B三异羟肟酸(DFO)而获得的。在这里报道的方法中,后者是一种源自(L)-鸟氨酸的天然六元环异羟肟酸。它通过(L)-赖氨酸间隔基与DFO偶联要求将DFO末端的真正胺官能团转变为羧酸。这样的要求促使我们探索能够挑战导致相同产物的全合成的短化学转化序列。事实上,目标C端DFO类似物以苄基保护的形式从市售DFO分三步获得,总收率为16%。我们的短步骤方法使我们能够在不扩展DFO的情况下引入其他官能团:-OH、-OTs、-CHO、-C(O)CH和-CH═CH。